GAMBIT Trial: A Randomized, Non-comparative, Open-label Clinical Trial Evaluating Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer [Estudo Clinico de Fase II, Randomizado, Avaliando a combinacao de Cisplatina e Irinotecano no Tratamento de Primeira Linha do Carcinoma da vesicula Biliar, Vias Biliares Intra ou Extra-hepaticas irressecavel ou metastatico (ESTUDO GAMBIT)]
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Gemcitabine; Irinotecan
- Indications Gallbladder cancer
- Focus Biomarker; Therapeutic Use
- Acronyms GAMBIT
- 18 Jan 2018 Biomarkers information updated
- 11 Jun 2013 New trial record